Search This Blog

Tuesday, October 30, 2018

Pfizer narrows FY18 adjusted EPS view to $2.98-$3.02 from $2.95-$3.05


FY18 consensus $2.99. Narrows FY18 revenue view to $53B-$53.7B from $53B-$55B, consensus $54.15B.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)